These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marín F; Lane DA; Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044 [TBL] [Abstract][Full Text] [Related]
6. Anticoagulation in heart failure without atrial fibrillation: gaps and dilemmas in current clinical practice. Siliste RN; Antohi EL; Pepoyan S; Nakou E; Vardas P Eur J Heart Fail; 2018 Jun; 20(6):978-988. PubMed ID: 29504188 [TBL] [Abstract][Full Text] [Related]
8. [For which patients with cardiac decompensation is prevention of thromboembolism advisable?]. G Ital Cardiol; 1994 Oct; 24(10):1341-6. PubMed ID: 7835568 [No Abstract] [Full Text] [Related]
9. Anticoagulation in patients with heart failure and normal sinus rhythm. Ripley TL; Nutescu E Am J Health Syst Pharm; 2009 Jan; 66(2):134-41. PubMed ID: 19139477 [TBL] [Abstract][Full Text] [Related]
10. What is the appropriate approach to prevention of thromboembolism in heart failure? Freudenberger RS; Schumaecker MM; Homma S Thromb Haemost; 2010 Mar; 103(3):489-95. PubMed ID: 20024492 [TBL] [Abstract][Full Text] [Related]
11. Antithrombotic therapy for heart failure in sinus rhythm. Subramaniam V; Davis RC; Shantsila E; Lip GY Fundam Clin Pharmacol; 2009 Dec; 23(6):705-17. PubMed ID: 19735305 [TBL] [Abstract][Full Text] [Related]
12. Antiplatelet and anticoagulant agents in heart failure: current status and future perspectives. Gurbel PA; Tantry US JACC Heart Fail; 2014 Feb; 2(1):1-14. PubMed ID: 24622113 [TBL] [Abstract][Full Text] [Related]
13. Anticoagulation Therapy and NOACs in Heart Failure. Thomas I; EncisoSilva J; Schlueter M; Greenberg B Handb Exp Pharmacol; 2017; 243():515-535. PubMed ID: 28233177 [TBL] [Abstract][Full Text] [Related]
14. Anticoagulation in atrial fibrillation with heart failure. Zhao L; Wang WYS; Yang X Heart Fail Rev; 2018 Jul; 23(4):563-571. PubMed ID: 29569146 [TBL] [Abstract][Full Text] [Related]
15. Prophylaxis and treatment of venous thromboembolism in patients with cancer. Ageno W; Squizzato A Intern Emerg Med; 2006; 1(4):260-2. PubMed ID: 17217144 [No Abstract] [Full Text] [Related]
16. Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial). Lee TC; Qian M; Lip GYH; Di Tullio MR; Graham S; Mann DL; Nakanishi K; Teerlink JR; Freudenberger RS; Sacco RL; Mohr JP; Labovitz AJ; Ponikowski P; Lok DJ; Estol C; Anker SD; Pullicino PM; Buchsbaum R; Levin B; Thompson JLP; Homma S; Ye S; Am J Cardiol; 2018 Sep; 122(5):821-827. PubMed ID: 30037426 [TBL] [Abstract][Full Text] [Related]
17. [Anticoagulation in chronic heart failure and left ventricular dysfunction]. Wichter T; Breithardt G Dtsch Med Wochenschr; 2002 Oct; 127(41):2145-8. PubMed ID: 12397561 [No Abstract] [Full Text] [Related]
18. Non-vitamin K antagonist oral anticoagulants and heart failure. Isnard R; Bauer F; Cohen-Solal A; Damy T; Donal E; Galinier M; Hagège A; Jourdain P; Leclercq C; Sabatier R; Trochu JN; Cohen A Arch Cardiovasc Dis; 2016 Nov; 109(11):641-650. PubMed ID: 27836786 [TBL] [Abstract][Full Text] [Related]
19. [Significance of anticoagulants in the treatment of cardiac insufficiency in patients with rheumatic defects of the heart]. Kushelevskiĭ BP; Rozhdestvenskaia ED Sov Med; 1967 Jul; 30(7):28-32. PubMed ID: 5607868 [No Abstract] [Full Text] [Related]
20. Antiplatelet and anticoagulant therapy in the prevention of thromboemboli in chronic heart failure. Garg RK; Gheorghiade M; Jafri SM Prog Cardiovasc Dis; 1998; 41(3):225-36. PubMed ID: 9872608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]